The financing is expected to support purchases of Nvidia Vera Rubin chips, with equipment deliveries anticipated in the first half of 2027.
Anthropic IPO option exercise removes potential stock support
Shares last traded at $86 on November 20, down 11.5%, after the underwriters exercised their full option to buy additional stock.

Morgan Stanley exercised an option to purchase all 147 million additional Anthropic shares available to the underwriting syndicate, Anthropic said on November 20. The purchase at the offering price increased the IPO's gross proceeds to roughly $93.5 billion.
Anthropic had appointed Morgan Stanley to help stabilize its shares following the listing. The option, called a greenshoe, allows underwriters to purchase stock from the issuer to cover shares sold beyond the original offering. Buying those shares in the market instead can provide price support.
Because the option has been exercised in full, Morgan Stanley no longer has the ability to cover any outstanding overallotment with market purchases should Anthropic trade below its $83 IPO price. That removes a potential source of demand for the stock.
The shares finished the preceding session at $97.17, about 17% above the offering price, before touching $85 during November 20 trading. A person familiar with the matter said market participants questioned the timing of the option exercise given volatility in the previous session. Morgan Stanley declined to comment.
In a client note, Carsten Hesse, Berenberg's London-based head of index events, said the extra proceeds benefited Anthropic, while investors were losing a potentially important buyer that could support the shares.
